A clinical study of drug Apamarga for the treatment in patients of Piles
Phase 2
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2023/08/056827
- Lead Sponsor
- Government Ayurvedic College Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age group 18-60 years
2 Sex both male and female
3 1st and 2nd grade of haemorrhoids
Exclusion Criteria
1 Pregnancy lactating mother
2 3rd and 4th grade of haemorrhoids
3 Patients with malignancy
4 Ulcerative colitis crohns disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective parameter Grading will be done with signs symptoms of Sravi Arsha <br/ ><br>Hb TLC DLC ESR LFT RFT Digital Examination Proctoscopy levels for Haemorrhoids.Timepoint: After one month intervention of Apamarga Ghana capsule orally 15 days after stopping of medicine
- Secondary Outcome Measures
Name Time Method Subjective Parameter- Grading will be done with signs & symptoms of Sravi Arsha respectively. HB,TLC,DLC,ESR,Digital Examination,LFT RFT Proctoscopy levels for HaemorrhoidsTimepoint: After one month intervention of Apamarga Ghana capsule orally 15 days after stopping of medicine